|
1
|
Wajchenberg BL, Mendonca BB, Liberman B,
Pereira MA, Carneiro PC, Wakamatsu A and Kirschner MA: Ectopic
adrenocorticotropic hormone syndrome. Endocr Rev. 15:752–787. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quaedvlieg PF, Visser O, Lamers CB,
Janssen-Heijen ML and Taal BG: Epidemiology and survival in
patients with carcinoid disease in the Netherlands. An
epidemiological study with 2391 patients. Ann Oncol. 12:1295–1300.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Modlin IM, Lye KD and Kidd M: A 5-decade
analysis of 13,715 carcinoid tumors. Cancer. 97:934–959. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hemminki K and Li X: Incidence trends and
risk factors of carcinoid tumors: A nationwide epidemiologic study
from Sweden. Cancer. 92:2204–2210. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fink G, Krelbaum T, Yellin A, Bendayan D,
Saute M, Glazer M and Kramer MR: Pulmonary carcinoid: Presentation,
diagnosis, and outcome in 142 cases in Israel and review of 640
cases from the literature. Chest. 119:1647–1651. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gatta G, Ciccolallo L, Kunkler I,
Capocaccia R, Berrino F, Coleman MP, De Angelis R, Faivre J, Lutz
JM, Martinez C, et al: EUROCARE Working Group: Survival from rare
cancer in adults: A population-based study. Lancet Oncol.
7:132–140. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: Epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–3072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuetenhorst JM and Taal BG: Metastatic
carcinoid tumors: A clinical review. Oncologist. 10:123–131. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Beasley MB, Brambilla E and Travis WD: The
2004 World Health Organization classification of lung tumors. Semin
Roentgenol. 40:90–97. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boddaert G, Grand B, Le Pimpec-Barthes F,
Cazes A, Bertagna X and Riquet M: Bronchial carcinoid tumors
causing Cushing's syndrome: More aggressive behavior and the need
for early diagnosis. Ann Thorac Surg. 94:1823–1829. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amer KM, Ibrahim NB, Forrester-Wood CP,
Saad RA and Scanlon M: Lung carcinoid related Cushing's syndrome:
Report of three cases and review of the literature. Postgrad Med J.
77:464–467. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Terzolo M, Reimondo G, Ali A, Bovio S,
Daffara F, Paccotti P and Angeli A: Ectopic ACTH syndrome:
Molecular bases and clinical heterogeneity. Ann Oncol. 12(Suppl 2):
S83–S87. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arioglu E, Doppman J, Gomes M, Kleiner D,
Mauro D, Barlow C and Papanicolaou DA: Cushing's syndrome caused by
corticotropin secretion by pulmonary tumorlets. N Engl J Med.
339:883–886. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shrager JB, Wright CD, Wain JC, Torchiana
DF, Grillo HC and Mathisen DJ: Bronchopulmonary carcinoid tumors
associated with Cushing's syndrome: A more aggressive variant of
typical carcinoid. J Thorac Cardiovasc Surg. 114:367–375. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aniszewski JP, Young WF Jr, Thompson GB,
Grant CS and van Heerden JA: Cushing syndrome due to ectopic
adrenocorticotropic hormone secretion. World J Surg. 25:934–940.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ilias I, Torpy DJ, Pacak K, Mullen N,
Wesley RA and Nieman LK: Cushing's syndrome due to ectopic
corticotropin secretion: Twenty years' experience at the National
Institutes of Health. J Clin Endocrinol Metab. 90:4955–4962. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de Matos LL, Trufelli DC, das
Neves-Pereira JC, Danel C and Riquet M: Cushing's syndrome
secondary to bronchopulmonary carcinoid tumor: Report of two cases
and literature review. Lung Cancer. 53:381–386. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mansi L, Rambaldi PF, Panza N, Esposito D,
Esposito V and Pastore V: Diagnosis and radioguided surgery with
111In-pentetreotide in a patient with paraneoplastic Cushing's
syndrome due to a bronchial carcinoid. Eur J Endocrinol.
137:688–690. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Markou A, Manning P, Kaya B, Datta SN,
Bomanji JB and Conway GS: [18F]fluoro-2-deoxy-D-glucose ([18F]FDG)
positron emission tomography imaging of thymic carcinoid tumor
presenting with recurrent Cushing's syndrome. Eur J Endocrinol:.
152:521–525. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zemskova MS, Gundabolu B, Sinaii N, Chen
CC, Carrasquillo JA, Whatley M, Chowdhury I, Gharib AM and Nieman
LK: Utility of various functional and anatomic imaging modalities
for detection of ectopic adrenocorticotropin-secreting tumors. J
Clin Endocrinol Metab. 95:1207–1219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gustafsson BI, Kidd M, Chan A,
Malfertheiner MV and Modlin IM: Bronchopulmonary neuroendocrine
tumors. Cancer. 113:5–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kara M, Ucar I, Yazicioglu A and Firat P:
An overlooked tumor of the lung in Cushing's syndrome:
Adrenocorticotropic hormone-secreting carcinoid tumor. Thorac
Cardiovasc Surg. 55:527–529. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ejaz S, Vassilopoulou-Sellin R, Busaidy
NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara
M and Habra MA: Cushing syndrome secondary to ectopic
adrenocorticotropic hormone secretion: The University of Texas MD
Anderson Cancer Center Experience. Cancer. 117:4381–4389. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dimopoulos MA, Fernandez JF, Samaan NA,
Holoye PY and Vassilopoulou-Sellin R: Paraneoplastic Cushing's
syndrome as an adverse prognostic factor in patients who die early
with small cell lung cancer. Cancer. 69:66–71. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Izzedine H, Besse B, Lazareth A, Bourry EF
and Soria JC: Hypokalemia, metabolic alkalosis, and hypertension in
a lung cancer patient. Kidney Int. 76:115–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Winquist EW, Laskey J, Crump M, Khamsi F
and Shepherd FA: Ketoconazole in the management of paraneoplastic
Cushing's syndrome secondary to ectopic adrenocorticotropin
production. J Clin Oncol. 13:157–164. 1995.PubMed/NCBI
|
|
27
|
Nagy-Mignotte H, Shestaeva O, Vignoud L,
Guillem P, Ruckly S, Chabre O, Sakhri L, Duruisseaux M, Mousseau M,
Timsit JF and Moro-Sibilot D: Multidisciplinary Thoracic Oncology
Group at Grenoble University Hospital, France: Prognostic impact of
paraneoplastic cushing's syndrome in small-cell lung cancer. J
Thorac Oncol. 9:497–505. 2014. View Article : Google Scholar : PubMed/NCBI
|
